Search
for
Sort by
Research 30 of 80
- Trends in the presence or absence of transaminitis and/or leukopenia in pediatric patients treated with methotrexate for inflammatory skin disease
- Valproate-Associated Transaminitis and Rhabdomyolysis
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Kava-induced acute cutaneous toxicity: An increasingly recognized characteristic clinicohistologic pattern
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- P075 A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata
- Overcoming hurdles: Side effects with old drugs and achieving success with novel drug in alopecia areata
- 151 Efficacy and adverse effects of oral Janus kinase inhibitor (JAKi) use in patients with lichen planopilaris: a retrospective case series and systematic review
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Adverse effect profile with low-dose methotrexate therapy in patients suffering with rheumatic diseases
- Hypertensive urgency in a child with focal epilepsy: Is it sodium valproate induced?
- Pityriasis rubra pilaris unveiling a case of a new onset hepatitis C infection
- Combined Alopecia Areata and Acquired Hypertrichosis Lanuginosa in Celiac Disease- A Rarest Phenomenon
- PLAU and SerpinB2 role in apoptosis in leprosy
- Verrucous hemangioma leg: A challenging birthmark
- Successful treatment of ulcerated infantile hemangioma associated with PELVIS syndrome using oral propanolol
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Acne in the adult female patient: a practical approach
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Side effects of common acne treatments
- Long COVID syndrome: An unfolding enigma
- Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Management of Toxicities of Targeted Therapies
- High-value dermatology: 5 Laboratory tests to reconsider